Literature DB >> 19037178

Unrecognized attention-deficit/hyperactivity disorder in adults presenting with other psychiatric disorders.

Russell A Barkley1, Thomas E Brown.   

Abstract

Many adults with a diagnosed psychiatric disorder also have attention-deficit/hyperactivity disorder (ADHD). In many cases, comorbid ADHD is unrecognized and/or undertreated. Differential diagnosis of adult ADHD can be challenging because ADHD symptoms may overlap with other psychiatric disorders and patients may lack insight into their ADHD-related symptoms. Current ADHD diagnostic criteria in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition-Text Revision may prevent appropriate diagnosis of many patients with significant ADHD symptoms. Adults may not be able to provide a history of onset of symptoms during childhood, and it may be difficult to confirm that ADHD symptoms are not better accounted for by other comorbid psychiatric conditions. Comorbid ADHD is most prevalent among patients with mood, anxiety, substance use, and impulse-control disorders. ADHD can negatively affect outcomes of other comorbid psychiatric disorders, and ADHD symptoms may compromise compliance with treatment regimens. Furthermore, unrecognized ADHD symptoms may be mistaken for poor treatment response in these comorbid disorders. In these individuals, ADHD pharmacotherapy seems to be as effective in reducing core ADHD symptoms, as it is in patients who have no comorbidity. Limited evidence further suggests that ADHD therapy may help to improve symptoms of certain psychiatric comorbidities, such as depression. Therefore, management of ADHD may help to stabilize daily functioning and facilitate a fuller recovery.

Entities:  

Mesh:

Year:  2008        PMID: 19037178     DOI: 10.1017/s1092852900014036

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


  32 in total

1.  A quantitative meta-analysis of neurocognitive functioning in posttraumatic stress disorder.

Authors:  J Cobb Scott; Georg E Matt; Kristen M Wrocklage; Cassandra Crnich; Jessica Jordan; Steven M Southwick; John H Krystal; Brian C Schweinsburg
Journal:  Psychol Bull       Date:  2014-11-03       Impact factor: 17.737

2.  Prospective relationships of ADHD symptoms with developing substance use in a population-derived sample.

Authors:  E Sihvola; R J Rose; D M Dick; T Korhonen; L Pulkkinen; A Raevuori; M Marttunen; J Kaprio
Journal:  Psychol Med       Date:  2011-05-20       Impact factor: 7.723

3.  International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder.

Authors:  Cleo L Crunelle; Wim van den Brink; Franz Moggi; Maija Konstenius; Johan Franck; Frances R Levin; Geurt van de Glind; Zsolt Demetrovics; Corné Coetzee; Mathias Luderer; Arnt Schellekens; Frieda Matthys
Journal:  Eur Addict Res       Date:  2018-03-06       Impact factor: 3.015

Review 4.  Current issues in the diagnosis of attention deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder.

Authors:  Paul J Frick; Joel T Nigg
Journal:  Annu Rev Clin Psychol       Date:  2011-12-21       Impact factor: 18.561

5.  Assessment of physician practices in adult attention-deficit/hyperactivity disorder.

Authors:  David W Goodman; Craig Bruce Surman; Priscilla B Scherer; Gregory D Salinas; Jennifer J Brown
Journal:  Prim Care Companion CNS Disord       Date:  2012-08-02

6.  Differences at brain SPECT between depressed females with and without adult ADHD and healthy controls: etiological considerations.

Authors:  Ann Gardner; Dario Salmaso; Andrea Varrone; Alejandro Sanchez-Crespo; Susanne Bejerot; Hans Jacobsson; Stig A Larsson; Marco Pagani
Journal:  Behav Brain Funct       Date:  2009-09-01       Impact factor: 3.759

Review 7.  Attention-deficit/hyperactivity disorder (ADHD).

Authors:  Søren Dalsgaard
Journal:  Eur Child Adolesc Psychiatry       Date:  2013-02       Impact factor: 4.785

8.  The utility of attention-deficit/hyperactivity disorder screening instruments in individuals seeking treatment for substance use disorders.

Authors:  Elias Dakwar; Amy Mahony; Martina Pavlicova; Andrew Glass; Daniel Brooks; John J Mariani; John Grabowski; Frances Rudnick Levin
Journal:  J Clin Psychiatry       Date:  2012-11       Impact factor: 4.384

9.  Management of attention-deficit hyperactivity disorder in adults: focus on methylphenidate hydrochloride.

Authors:  Rajasree Nair; Shannon B Moss
Journal:  Neuropsychiatr Dis Treat       Date:  2009-08-20       Impact factor: 2.570

10.  ADHD-related symptoms among adults in out-patient psychiatry and female prison inmates as compared with the general population.

Authors:  Dan Edvinsson; Kerstin Bingefors; Eva Lindström; Tommy Lewander
Journal:  Ups J Med Sci       Date:  2010-02       Impact factor: 2.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.